Therapy Areas: Autoimmune
Samsung Biologics signs strategic partnership with Kanaph Therapeutics
24 September 2020 - South Korea-based Samsung Biologics (207940.KS) has signed a strategic partnership with Kanaph Therapeutics, it was reported on Wednesday.The contract has been signed to develop KN...
Prostate Conditions Education Council offers free screening diagnosis of prostate cancer amidst COVID-19 crisis
22 September 2020 - Prostate cancer screening company Prostate Conditions Education Council (PCEC) said on Monday that it is providing free prostate cancer testing to men across the country following ...
US FDA Grants IND, Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
21 September 2020 - - US-based biopharmaceutical company Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) has been granted an Investigational New Drug from the US Food and Drug Administration, allowi...
European authority issues positive opinion for baricitinib to Eli Lilly and and Incyte
21 September 2020 - The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued United States-based Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:...
Synthekine Launches with USD 82m series A Financing to Advance Pipeline of Engineered Cytokine Therapeutics Optimized for Cancer and Autoimmune Diseases
18 September 2020 - - US-based engineered cytokine therapeutics company Synthekine Inc has closed an USD 82m series A financing, the company said.

The financing was co-led by Canaan Partn...
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
16 September 2020 - - US-based biopharmaceutical companies Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) have received initial data emerging from the Adaptive COVID-19 Treatment Tri...
Related Headlines

UCB announces positive phase II study results for rozanolixizumab

AbbVie, I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

Calliditas Therapeutics AB doses first patient in China under clinical phase 3 study NefIgArd with Nefecon

Xencor, MD Anderson Enter Strategic Collaboration to Advance Investigational XmAb Drug Candidates

Savara to Discontinue Exploratory ENCORE Study Evaluating Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis

City of Hope Doctors Lead Novel Clinical Trial to Treat Cancer Patients with COVID-19

FDA Clears Can-Fite to Start Phase II COVID-19 Study

Ligand OmniAb Partner Immunovant Touts Positive Topline Results from Multicenter, Placebo-Controlled Phase 2a Trial of IMVT-1401 in Myasthenia Gravis

Bio-Thera Solutions, BeiGene Ink License, Distribution, and Supply Agreement for Avastin Biosimilar BAT1706 in China

Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients

FDA Approves Genentech's Enspryng for Neuromyelitis Optica Spectrum Disorder

I-Mab doses first patient with Plonmarlimab in phase 1b rheumatoid arthritis study

IAVI and Wellcome Issue a Global Call to Action: Monoclonal Antibodies for COVID-19 and Other Diseases Could Save Millions of Lives

Novocellbio in Korea Confirms NOVO-NK's Promising Antiviral Effects Against COVID-19

Neutrolis Develops First-In-Class Treatment Targeting Neutrophil Extracellular Traps For Patients With Severe COVID-19